Motility News

Temperature-controlled delivery of radiofrequency energy using the Secca procedure improved severe fecal incontinence better than a sham procedure in a randomized controlled trial.

August is Gastroparesis Awareness Month. First listed on the U.S. National Health Observances Calendar in 2016 with sponsorship by the International Foundation for Functional Gastrointestinal Disorders, this awareness initiative aims to focus attention on diagnosis, treatment and quality of life issues associated with this poorly understood motility condition that prevents the stomach from properly emptying.

RedHill Biopharma Ltd. received exclusive rights to promote its FDA-approved esomeprazole strontium delayed-release capsules to gastroenterologists in select territories in the United States, according to a press release.

Gastric per-oral endoscopic pyloromyotomy, or GPOEM, resulted in overall improvement in gastroparesis symptoms, as well as improved gastric emptying and quality of life, according to recent study data.

For the first time, researchers characterized normal bowel habits for adults in the United States.

A new study showed “notable variation” in the overall use of antireflux surgery in infants with GERD, and in the surgical approach and diagnostic testing.

RD Biomed has registered Peptest, a noninvasive device that diagnoses GERD by using antibodies to detect the gastric enzyme pepsin in saliva, sputum or exhaled condensate samples, as a low-risk Class 1 Medical Device with the FDA.

Velusetrag safely improved symptoms and normalized gastric emptying in both diabetic and idiopathic gastroparesis in a phase 2b trial, the manufacturer announced.

A pair of studies published in the Journal of Parkinson’s Disease shed light on the burden of constipation and GI dysfunction in patients with Parkinson’s disease.

Patients with gastroparesis may experience symptoms for 5 years before they receive an accurate diagnosis. This indicates that broader awareness among health care providers and the public, and better treatments remain necessary to improve care and outcomes, according to a press release.